SCHEMBL9703752

SCHEMBL9703752

Nc1ccccc1S(=O)(=O)Nc1cnc2c(Cl)cccc2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.54
SLC40A1 Q9NP59 7/20 0.48
NFKBIA P25963 2/20 0.48
RELA Q04206 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
LMNA P02545 3/20 0.47
CYP2C9 P11712 1/20 0.47
HSD11B1 P28845 1/20 0.44
POLB P06746 1/20 0.42
CASP6 P55212 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
SGK1 O00141 2/20 0.41
CYP3A4 P08684 1/20 0.39
SGK3 Q96BR1 1/20 0.39
SGK2 Q9HBY8 1/20 0.39
PPARG P37231 1/20 0.39
USP2 O75604 1/20 0.38
ALPL P05186 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1385573 0.83 LMNA (0.66) PKMSLC40A1NFKBIARELATDP1
Chlorsulfaquinoxaline SCHEMBL29557567 0.81 LMNA (0.68) TDP1MEN1KMT2ALMNACYP2C9
Chlorsulfaquinoxaline SCHEMBL6375915 0.81 LMNA (0.68) TDP1MEN1KMT2ALMNACYP2C9
SCHEMBL9231574 0.78 PDPK1 (0.53) PKMSLC40A1TDP1MEN1KMT2A
SCHEMBL5323047 0.77 LMNA (0.61) PKMSLC40A1NFKBIARELATDP1
SCHEMBL23773188 0.77 LMNA (0.51) PKMMEN1KMT2ALMNACYP2C9
SCHEMBL10761503 0.74 HSD11B1 (0.41) PKMSLC40A1NFKBIARELATDP1
SCHEMBL3163793 0.72 POLB (0.64) PKMMEN1KMT2ALMNAPOLB
SCHEMBL9230544 0.71 HTR2C (0.45) PKMMEN1KMT2ALMNACYP2C9
SCHEMBL9075934 0.71 PIK3CD (0.45) MEN1KMT2ALMNACYP2C9POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101163468-A Novel combination of sulfonamide compounds EISAI R&D MAN CO LTD (JP) 2008-04-16 CN claimed
EP-0215200-B1 USE OF SULFANILAMIDO QUINOXALINES IN THE TREATMENT OF NEOPLASTIC DISEASES MERCK & CO. INC. (US) 1992-09-09 EP claimed
US-4931433-A Method for treating certain neoplastic diseases MERCK & CO., INC. (US) 1990-06-05 US claimed
EP-0215200-A2 Use of sulfanilamido quinoxalines in the treatment of neoplastic diseases MERCK & CO. INC. (US) 1987-03-25 EP claimed
CN-101163468-A Novel combination of sulfonamide compounds EISAI R&D MAN CO LTD (JP) 2008-04-16 CN disclosed
EP-0215200-B1 USE OF SULFANILAMIDO QUINOXALINES IN THE TREATMENT OF NEOPLASTIC DISEASES MERCK & CO. INC. (US) 1992-09-09 EP disclosed
US-4931433-A Method for treating certain neoplastic diseases MERCK & CO., INC. (US) 1990-06-05 US disclosed
EP-0215200-A2 Use of sulfanilamido quinoxalines in the treatment of neoplastic diseases MERCK & CO. INC. (US) 1987-03-25 EP disclosed